Gatifloxacin-induced hyperglycemia

Infectious Diseases in Clinical Practice

Volumn 12, Issue 4, 2004, Pages 230-232

  Orlander, Jay D ^a,b   Serrao, Richard ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; AZITHROMYCIN; BECLOMETASONE; CAPTOPRIL; CITALOPRAM; DIGOXIN; EYE DROPS; FERROUS SULFATE; FUROSEMIDE; GATIFLOXACIN; GLIPIZIDE; GLUCOSE; ISOSORBIDE MONONITRATE; METOPROLOL; PSEUDOEPHEDRINE; RABEPRAZOLE; SIMVASTATIN; SPIRONOLACTONE; WARFARIN;

AGED; ANEMIA; ARTICLE; CARDIOMYOPATHY; CASE REPORT; DIABETES MELLITUS; DRUG INDUCED DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LUNG DISEASE; MALE; OXYGEN THERAPY; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; THORAX RADIOGRAPHY;

EID: 3242672460     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000130884.04988.d5     Document Type: Article

References (13)

1. Baker SE, Hangii MC. Possible gatifloxacin-induced hypoglycemia. Ann Pharmacother. 2002;36:1722-1726.
2. Menzies DJ, Dorsainvil PA, Cunha BA, et al. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents. Am J Med. 2002;113(3):232-234.
3. Briggs WS. Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients. J Am Board Fam Pract. 2003;16(5): 455-457.
4. Gajjar DA, LaCreta FP, Kollia GD, et al. Effect of multi-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with non-insulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy. 2000;20(suppl): 76S-86S.
5. Tequin (gatifloxacin) [package insert] Princeton, NJ: Bristol-Myers Squibb Co; 2002.
6. Leslie PJ, Creegeen RJ, Proudfoot AT. Lactic acidosis, hyperglycaemia and convulsions following nalidixic acid overdosage. Hum Toxicol. 1984;3(3):239-243.
7. Fraser AG, Harrower AD. Convulsions and hyperglycaemia associated with nalidixic acid. BMJ. 1977;2(6101):1518.
8. NegGram (nalidixic acid). Prescribing information, Sanofi-Synthelabo, Inc. Revised November 2000. Available at: http://www.sanofi-synthelabo. us/index.html. Accessed May 6, 2004.
9. Cipro (ciprofloaxacin). Prescribing information. West Haven, CT: Bayer Pharmaceuticals Corp. July 2002, Available at: http://www.univgraph. com/bayer/INSERTS/CIPROTAB.pdf. Accessed May 7, 2003.
10. Levaquin (levofloxacin). Prescribing information. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc. Revised January 2003. Available at: http://www,ortho-mcneil.com/products/pi/pdfs/levatab.pdf. Accessed May 7, 2003.
11. Avelox (moxifloxacin). Prescribing information. West Haven, CT: Bayer Pharmaceuticals Corp. Revised March 2003. Available at: http://www.univgraph. com/Bayer/inserts/Avelox.pdf. Accessed May 7, 2003.
12. Roberge RJ, Kaplan R, Frank R, Fore C. Glyburide-ciprofloxacin interaction with resistant hypoglycemia. Ann Emerg Med. 2000;36:160-163.
13. Whiteley M, Worlding J, Patel S, et al. Hypoglycemia in a diabetic patient, associated with ciprofloxacin therapy [case report]. Pract Diabetes. 1993;10:35.